21.95
price down icon1.79%   -0.40
after-market アフターアワーズ: 21.95
loading
前日終値:
$22.35
開ける:
$22.44
24時間の取引高:
222.82K
Relative Volume:
0.46
時価総額:
$1.08B
収益:
-
当期純損益:
$-85.21M
株価収益率:
-11.61
EPS:
-1.89
ネットキャッシュフロー:
$-68.53M
1週間 パフォーマンス:
-5.96%
1か月 パフォーマンス:
+3.73%
6か月 パフォーマンス:
+0.41%
1年 パフォーマンス:
-8.58%
1日の値動き範囲:
Value
$21.80
$22.83
1週間の範囲:
Value
$21.38
$24.38
52週間の値動き範囲:
Value
$13.30
$30.03

Enliven Therapeutics Inc Stock (ELVN) Company Profile

Name
名前
Enliven Therapeutics Inc
Name
セクター
Healthcare (1161)
Name
電話
720-647-8519
Name
住所
6200 LOOKOUT ROAD, BOULDER
Name
職員
65
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ELVN's Discussions on Twitter

ELVN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ELVN
Enliven Therapeutics Inc
21.95 1.27B 0 -85.21M -68.53M -1.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-16 開始されました Goldman Buy
2024-12-13 開始されました BTIG Research Buy
2024-09-09 開始されました H.C. Wainwright Buy
2024-06-11 開始されました Robert W. Baird Outperform
2024-04-09 開始されました Mizuho Buy
2023-03-29 開始されました Jefferies Buy
すべてを表示

Enliven Therapeutics Inc (ELVN) 最新ニュース

pulisher
Jul 24, 2025

Polis encourages life-sciences companies to move to Colorado - BizWest

Jul 24, 2025
pulisher
Jul 23, 2025

Enliven Therapeutics Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Enliven Therapeutics Inc. stockOutstanding investment returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Enliven Therapeutics Inc. a good long term investmentTriple-digit growth rates - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Enliven Therapeutics CSO sells $278k in shares - Investing.com Australia

Jul 23, 2025
pulisher
Jul 23, 2025

Enliven Therapeutics CSO sells $278k in shares By Investing.com - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Enliven Therapeutics’ Promising CML Study Update: What Investors Need to Know - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Enliven Therapeutics Inc. stock priceOutstanding capital growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Samuel Kintz Sells 12,500 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

Why Enliven Therapeutics Inc. stock attracts strong analyst attentionDaily Price Surge List - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

Can Enliven Therapeutics, Inc. (ELVN) Climb 75.66% to Reach the Level Wall Street Analysts Expect? - MSN

Jul 20, 2025
pulisher
Jul 19, 2025

Enliven Therapeutics’ Promising Phase 1a/1b Study on ELVN-002 in HER2+ Cancers - The Globe and Mail

Jul 19, 2025
pulisher
Jul 19, 2025

Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Enliven Therapeutics (ELVN) - The Globe and Mail

Jul 19, 2025
pulisher
Jul 18, 2025

Will Enliven Therapeutics Inc. stock split in the near futureTop Performing Low Risk Stocks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Enliven Therapeutics’ Promising CML Treatment: A Study Update - TipRanks

Jul 17, 2025
pulisher
Jul 15, 2025

What makes Enliven Therapeutics Inc. stock price move sharplyFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Enliven Therapeutics Inc. stock performs during market volatilityInsider Strategy Insight - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

(ELVN) Proactive Strategies - news.stocktradersdaily.com

Jul 15, 2025
pulisher
Jul 15, 2025

Enliven Therapeutics CFO Hohl sells $22,655 in shares - Investing.com Australia

Jul 15, 2025
pulisher
Jul 14, 2025

Brokerages Set Enliven Therapeutics, Inc. (NASDAQ:ELVN) Target Price at $41.20 - Defense World

Jul 14, 2025
pulisher
Jul 10, 2025

Enliven Therapeutics Breaks Above 200-Day Moving AverageBullish for ELVN - Nasdaq

Jul 10, 2025
pulisher
Jul 09, 2025

Enliven Therapeutics COO Patel sells shares worth $131950 By Investing.com - Investing.com Canada

Jul 09, 2025
pulisher
Jul 09, 2025

Enliven Therapeutics COO Patel sells shares worth $131950 - Investing.com

Jul 09, 2025
pulisher
Jul 05, 2025

HC Wainwright Brokers Increase Earnings Estimates for ELVN - Defense World

Jul 05, 2025
pulisher
Jul 04, 2025

(ELVN) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 04, 2025

Enliven Therapeutics Inc (ELVN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
大文字化:     |  ボリューム (24 時間):